US Stock MarketDetailed Quotes

ZVSA ZyVersa Therapeutics

Watchlist

1.4000
-0.1200-7.89%

Close Nov 8 16:00 ET

1.4400
+0.0400+2.86%

Post 16:49 ET

1.50MMarket Cap-53P/E (TTM)

ZyVersa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 12, 2022

(Q4)Dec 12, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-369.58%-1.91M

17.71%-3.78M

-483.47%-8.72M

-569.54%-2.79M

-140.80%-936.4K

-29.19%-407.62K

-1,127.29%-4.59M

70.56%-1.49M

32.44%-416.31K

44.32%-388.86K

Net income from continuing operations

96.48%-2.76M

20.24%-2.83M

-599.75%-98.3M

-189.82%-13.34M

21.40%-2.9M

-3,817.40%-78.51M

5.46%-3.54M

-73.77%-14.05M

-133.72%-4.6M

-96.43%-3.69M

Operating gains losses

----

237.46%607K

1,627.88%186.4K

149.59%228.1K

Depreciation and amortization

0.00%2.6K

5.39%10.4K

25.73%2.6K

0.00%2.6K

-5.12%9.87K

-20.46%2.07K

0.00%2.6K

Deferred tax

100.12%9.71K

--0

---9.48M

---596.07K

---485

---7.84M

---1.05M

--0

Other non cash items

--0

-79.14%87.04K

1,507.01%1.92M

12.19%89.66K

159.33%22.82K

5,414.68%1.39M

690.78%417.25K

-62.43%119.41K

21.28%79.92K

-144.27%-38.46K

Change In working capital

-77.51%676.68K

-78.97%-1.26M

-68.64%2.6M

-139.72%-1.4M

-35.13%1.7M

205.54%3.01M

-160.56%-705.76K

912.68%8.29M

642.30%3.52M

1,604.21%2.62M

-Change in prepaid assets

-63.06%264.57K

40.61%-651.02K

-41.37%193.07K

-50.33%112.58K

-49.82%460.39K

257.61%716.3K

-204.19%-1.1M

210.84%329.3K

840.05%226.67K

2,821.28%917.49K

-Change in payables and accrued expense

-82.21%412.11K

-245.50%-603.4K

-68.85%2.51M

-143.94%-1.49M

-23.71%1.26M

58.50%2.32M

-73.21%414.69K

1,212.90%8.05M

569.51%3.38M

1,254.84%1.66M

-Change in other current liabilities

--0

64.30%-8.66K

-16.26%-100.1K

70.16%-25.69K

-156.64%-25.28K

-10.10%-24.88K

-10.09%-24.25K

---86.1K

--44.63K

Cash from discontinued investing activities

Operating cash flow

-369.58%-1.91M

17.71%-3.78M

-483.47%-8.72M

-569.54%-2.79M

-140.80%-936.4K

-29.19%-407.62K

-1,127.29%-4.59M

70.56%-1.49M

32.44%-416.31K

44.32%-388.86K

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

7,807.50%2.67M

219.31%5.96M

747.43%4.35M

244.96%2.29M

-316.52%-641.76K

-108.82%-34.67K

-64.33%1.87M

512.88K

662.8K

Net common stock issuance

----

--18.11M

--5M

--2.1M

----

--0

Net preferred stock issuance

----

-644.44%-10.7M

-100.00%-1

-123.08%-230K

----

--1.96M

--548.8K

--996.4K

Proceeds from stock option exercised by employees

--0

--2.67M

--967.48K

--179

3,617.65%967.3K

--0

--26.02K

Net other financing activities

----

-2,343.61%-2.42M

-1,719.30%-653.51K

-52.92%-549.93K

-467.37%-1.18M

-33.26%-34.67K

---99.14K

---35.92K

---359.62K

Cash from discontinued financing activities

Financing cash flow

--0

7,807.50%2.67M

219.31%5.96M

747.43%4.35M

244.96%2.29M

-316.52%-641.76K

-108.82%-34.67K

-64.33%1.87M

--512.88K

--662.8K

Net cash flow

Beginning cash position

59.11%2.03M

-46.84%3.14M

1,696.27%5.9M

161.92%1.58M

-30.45%228.69K

267.34%1.28M

1,696.27%5.9M

88.12%328.58K

-36.20%602.75K

-79.99%328.82K

Current changes in cash

-82.40%-1.91M

76.12%-1.1M

-845.67%-2.76M

1,514.27%1.56M

392.83%1.35M

-5,389.54%-1.05M

-23,997.29%-4.62M

140.88%370.74K

115.67%96.57K

139.23%273.94K

End cash Position

-47.75%119.49K

59.11%2.03M

348.67%3.14M

161.92%1.58M

-30.45%228.69K

267.34%1.28M

112.83%699.32K

-36.20%602.75K

Free cash flow

-369.58%-1.91M

17.71%-3.78M

-483.47%-8.72M

-569.54%-2.79M

-140.80%-936.4K

-29.19%-407.62K

-1,127.29%-4.59M

70.56%-1.49M

32.44%-416.31K

44.32%-388.86K

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 12, 2022	(Q4)Dec 12, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-369.58%-1.91M	17.71%-3.78M	-483.47%-8.72M	-569.54%-2.79M	-140.80%-936.4K	-29.19%-407.62K	-1,127.29%-4.59M	70.56%-1.49M	32.44%-416.31K	44.32%-388.86K
Net income from continuing operations	96.48%-2.76M	20.24%-2.83M	-599.75%-98.3M	-189.82%-13.34M	21.40%-2.9M	-3,817.40%-78.51M	5.46%-3.54M	-73.77%-14.05M	-133.72%-4.6M	-96.43%-3.69M
Operating gains losses	----	----	----	----	----	----	----	237.46%607K	1,627.88%186.4K	149.59%228.1K
Depreciation and amortization	0.00%2.6K	0.00%2.6K	5.39%10.4K	25.73%2.6K	0.00%2.6K	0.00%2.6K	0.00%2.6K	-5.12%9.87K	-20.46%2.07K	0.00%2.6K
Deferred tax	100.12%9.71K	--0	---9.48M	---596.07K	---485	---7.84M	---1.05M	--0	--0	--0
Other non cash items	--0	-79.14%87.04K	1,507.01%1.92M	12.19%89.66K	159.33%22.82K	5,414.68%1.39M	690.78%417.25K	-62.43%119.41K	21.28%79.92K	-144.27%-38.46K
Change In working capital	-77.51%676.68K	-78.97%-1.26M	-68.64%2.6M	-139.72%-1.4M	-35.13%1.7M	205.54%3.01M	-160.56%-705.76K	912.68%8.29M	642.30%3.52M	1,604.21%2.62M
-Change in prepaid assets	-63.06%264.57K	40.61%-651.02K	-41.37%193.07K	-50.33%112.58K	-49.82%460.39K	257.61%716.3K	-204.19%-1.1M	210.84%329.3K	840.05%226.67K	2,821.28%917.49K
-Change in payables and accrued expense	-82.21%412.11K	-245.50%-603.4K	-68.85%2.51M	-143.94%-1.49M	-23.71%1.26M	58.50%2.32M	-73.21%414.69K	1,212.90%8.05M	569.51%3.38M	1,254.84%1.66M
-Change in other current liabilities	--0	64.30%-8.66K	-16.26%-100.1K	70.16%-25.69K	-156.64%-25.28K	-10.10%-24.88K	-10.09%-24.25K	---86.1K	---86.1K	--44.63K
Cash from discontinued investing activities
Operating cash flow	-369.58%-1.91M	17.71%-3.78M	-483.47%-8.72M	-569.54%-2.79M	-140.80%-936.4K	-29.19%-407.62K	-1,127.29%-4.59M	70.56%-1.49M	32.44%-416.31K	44.32%-388.86K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	0	7,807.50%2.67M	219.31%5.96M	747.43%4.35M	244.96%2.29M	-316.52%-641.76K	-108.82%-34.67K	-64.33%1.87M	512.88K	662.8K
Net common stock issuance	----	----	--18.11M	--5M	--2.1M	----	----	--0	--0	--0
Net preferred stock issuance	----	----	-644.44%-10.7M	-100.00%-1	-123.08%-230K	----	----	--1.96M	--548.8K	--996.4K
Proceeds from stock option exercised by employees	--0	--2.67M	--967.48K	--179	3,617.65%967.3K	--0	--0	--0	--0	--26.02K
Net other financing activities	----	----	-2,343.61%-2.42M	-1,719.30%-653.51K	-52.92%-549.93K	-467.37%-1.18M	-33.26%-34.67K	---99.14K	---35.92K	---359.62K
Cash from discontinued financing activities
Financing cash flow	--0	7,807.50%2.67M	219.31%5.96M	747.43%4.35M	244.96%2.29M	-316.52%-641.76K	-108.82%-34.67K	-64.33%1.87M	--512.88K	--662.8K
Net cash flow
Beginning cash position	59.11%2.03M	-46.84%3.14M	1,696.27%5.9M	161.92%1.58M	-30.45%228.69K	267.34%1.28M	1,696.27%5.9M	88.12%328.58K	-36.20%602.75K	-79.99%328.82K
Current changes in cash	-82.40%-1.91M	76.12%-1.1M	-845.67%-2.76M	1,514.27%1.56M	392.83%1.35M	-5,389.54%-1.05M	-23,997.29%-4.62M	140.88%370.74K	115.67%96.57K	139.23%273.94K
End cash Position	-47.75%119.49K	59.11%2.03M	348.67%3.14M	348.67%3.14M	161.92%1.58M	-30.45%228.69K	267.34%1.28M	112.83%699.32K	112.83%699.32K	-36.20%602.75K
Free cash flow	-369.58%-1.91M	17.71%-3.78M	-483.47%-8.72M	-569.54%-2.79M	-140.80%-936.4K	-29.19%-407.62K	-1,127.29%-4.59M	70.56%-1.49M	32.44%-416.31K	44.32%-388.86K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data